[Postmenopausal osteoporosis].
Noda
Masaki
M
Department of Molecular Pharmacology, Medical Research Institute, Tokyo Medical and Dental University.
Hino
Kazunori
K
Kondo
Hisataka
H
D000818:Animals; D016723:Bone Remodeling / Q000235:genetics / Q000276:immunology; D001842:Bone and Bones / Q000378:metabolism; D002352:Carrier Proteins / Q000502:physiology; D015232:Dinoprostone / Q000502:physiology; D005260:Female; D006801:Humans; D026502:LDL-Receptor Related Proteins / Q000502:physiology; D060492:Low Density Lipoprotein Receptor-Related Protein-5; D008562:Membrane Glycoproteins / Q000502:physiology; D010006:Osteoblasts / Q000502:physiology; D015675:Osteocalcin / Q000502:physiology; D010010:Osteoclasts / Q000502:physiology; D015663:Osteoporosis, Postmenopausal / Q000209:etiology / Q000378:metabolism; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D013601:T-Lymphocytes / Q000276:immunology; D051153:Wnt Proteins / Q000502:physiology
D002352:Carrier Proteins; D026502:LDL-Receptor Related Proteins; C555482:LRP5 protein, human; D060492:Low Density Lipoprotein Receptor-Related Protein-5; D008562:Membrane Glycoproteins; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; C505686:TNFRSF11A protein, human; C505688:TNFSF11 protein, human; D051153:Wnt Proteins; D015675:Osteocalcin; D015232:Dinoprostone